Headlines
- 2024 DTA Summit: Focus on Revenue Pathways
- DTA Announces DTx Accreditation Program in Partnership with DirectTrust
- Upcoming Webinar: Cross-Regional Learnings: Insights from Europe to APAC
DTx in the News
- DTA Member & Industry News
2024 DTA Summit: Focus on Revenue Pathways
The 2024 Digital Therapeutics Alliance (DTA) Summit was an unparalleled gathering of industry stakeholders, united in their commitment to advancing the DTx landscape.
The DTx industry is looking positive and DTA is laser focused on establishing revenue pathways with the following:
- Expanding HCPCS coding through CMS by actively petitioning CMS and having legislators pressure CMS to expand codes
- Creating a new benefit category for digital therapeutics through legislative advocacy in the PDT bill or inclusion in other bills
- Establishing Payment from state Medicaid programs and commercial plans through federal legislation for Medicaid coverage, expanded coding, and demonstrating cost savings
- Expanding CPT coding and provider services by identify gaps in current coding schema, filing CPT applications through AMA, and seeking codes for other physician services from CMS
- DTA is leading the charge in implementing PDURS. The recent PDURS regulatory guidance provides a pathway for drug manufacturers to offer software alongside their medication. . DTA is spearheading efforts to evaluate payment pathways and tackle potential regulatory pitfalls by proactively engaging with regulatory agencies. DTA is working to ensure a clear regulatory and payment pathway, leaving no room for complications.
- DTA is working internationally to build and harmonize international regulatory and payment pathways ensuring DTx products can scale and reach patients worldwide.
If you have an AI-driven therapeutic product, a pharma or drug product with a software companion, or are involved in hospital-at-home initiatives, your participation is crucial!
| Learn More about DTA |
Thank you to the Summit Sponsors!
DTA Announces DTx Accreditation Program in Partnership with DirectTrust
DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare data exchange through standards, accreditation, and other services, and Digital Therapeutics Alliance (DTA) announced a collaborative partnership that will provide accreditation for efficacy, data privacy and security for digital therapeutics applications and platforms (DTx).
Through this strategic partnership, DTA and DirectTrust will develop a program set to expand existing DirectTrust programs that provide independent assessment of health apps for privacy, security, and transparency, as well as interoperability compliance with regulations and best practices. DirectTrust will administer the program, while DTA will lead the criteria development.
Stakeholders with an interest in participating as a beta organization for accreditation, or in joining the Criteria Council subgroup can complete the form on the DirectTrust website at bit.ly/DTDTx, or email Admin@DirectTrust.org.
Upcoming Webinar: Cross-Regional Learnings: Insights from Europe to APAC
DTx have emerged as a transformative force in healthcare, offering evidence-based interventions to prevent, manage, or treat medical disorders. Europe, particularly countries like France and Germany, has paved the way in DTx innovation, boasting successful regulatory frameworks and reimbursement models. As the APAC region seeks to embrace and integrate DTx into its healthcare ecosystem, understanding the European experience becomes paramount. This webinar aims to provide a comprehensive exploration of the European landscape in DTx, offering insights, best practices, and lessons learned that can be applied in the APAC context.
Can’t attend at this time? Register to receive the recording post-event.
📰 DTx in the News
- CDRH Issues Guiding Principles for Transparency of Machine Learning-Enabled Medical Devices | FDA
- Transparency for Machine Learning-Enabled Medical Devices: Guiding Principles | FDA
- Digital Therapeutics Alliance conference, Day 1—Following a rocky year, high hopes for the industry
- Digital Therapeutics Alliance conference, Day 2—’These were the kinds of moments that Google was born in’
- DirectTrust(R) and Digital Therapeutics Alliance Announce Partnership to Provide Accreditation for Digital Therapeutics Industry
- Payers: Digital Health Investments Increase Member Satisfaction
- Sidekick Health acquires PINK! to bolster its femtech offering
- Digital therapeutics progress is growing amid coverage challenges, interview with Andy Molnar